Stem cells as a potential therapy for diabetes mellitus: a call-to-action in Latin America

Diabetology & Metabolic Syndrome
Mairim Alexandra SolisLynn L H Huang

Abstract

Latin America is a fast-growing region that currently faces unique challenges in the treatment of all forms of diabetes mellitus. The burden of this disease will be even greater in the coming years due, in part, to the large proportion of young adults living in urban areas and engaging in unhealthy lifestyles. Unfortunately, the national health systems in Latin-American countries are unprepared and urgently need to reorganize their health care services to achieve diabetic therapeutic goals. Stem cell research is attracting increasing attention as a promising and fast-growing field in Latin America. As future healthcare systems will include the development of regenerative medicine through stem cell research, Latin America is urged to issue a call-to-action on stem cell research. Increased efforts are required in studies focused on stem cells for the treatment of diabetes. In this review, we aim to inform physicians, researchers, patients and funding sources about the advances in stem cell research for possible future applications in diabetes mellitus. Emerging studies are demonstrating the potential of stem cells for β cell differentiation and pancreatic regeneration. The major economic burden implicated in patients with diabete...Continue Reading

References

Apr 1, 1990·Diabetes·G C WeirJ L Leahy
May 14, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Guillermo Muñoz-EliasIra B Black
Jun 24, 2004·Journal of the American Society of Nephrology : JASN·Marina MorigiGiuseppe Remuzzi
Jul 21, 2005·The British Journal of Dermatology·H NakagawaK Akino
Mar 9, 2006·Health Affairs·Mark V PaulyMark Bassett
Nov 9, 2006·Proceedings of the National Academy of Sciences of the United States of America·Bart KeymeulenDaniel Pipeleers
Dec 23, 2006·Development·L Charles Murtaugh
Apr 5, 2007·Nature Protocols·Insa S SchroederAnna M Wobus
Apr 12, 2007·JAMA : the Journal of the American Medical Association·Júlio C VoltarelliRichard K Burt
Jun 26, 2007·Biochemical and Biophysical Research Communications·Po-Yang ChenHsyue-Jen Hsieh
Sep 21, 2007·Endocrine Reviews·Mette Christine JørgensenJacob Hecksher-Sørensen
May 21, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Fernando E EzquerPaulette A Conget
Oct 14, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Fernando EzquerPaulette Conget
Nov 17, 2009·Journal of Molecular Cell Biology·Jun CaiHongkui Deng
Dec 19, 2009·Proceedings of the National Academy of Sciences of the United States of America·Meritxell RoviraSteven D Leach
Jan 13, 2012·Diabetes Care·Crystal M Smith-SpanglerJeremy D Goldhaber-Fiebert
Jun 28, 2012·International Journal of Epidemiology·Carlotta SacerdoteNicholas Wareham
Jan 8, 2013·Transplantation Reviews·Peiman HemattiDixon Kaufman
Apr 23, 2013·Journal of Cellular Biochemistry·Renjitha GopurappillyRamesh Bhonde
Oct 15, 2013·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Alejandro MesplesXiang Hu
Dec 21, 2013·Diabetes Care·UNKNOWN American Diabetes Association
Dec 21, 2013·Diabetes Care·UNKNOWN American Diabetes Association
Apr 29, 2014·World Journal of Stem Cells·Marina FigliuzziAndrea Remuzzi

❮ Previous
Next ❯

Methods Mentioned

BETA
amputation

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.